Published Manuscripts

1. Monoclonal antibody-induced cytokine-release syndrome.  Bugelski PJ, Achuthanandam R, Capocasale RJ, Treacy G, Bouman-Thio E., Expert Rev Clin Immunol. 2009 Sep;5(5):499-521.
2. Sequential univariate gating approach to study the effects of erythropoietin in murine bone marrow. Achuthanandam R, Quinn J, Capocasale RJ, Bugelski PJ, Hrebien L, Kam M., Cytometry A. 2008 Aug;73(8):702-14.
3. J Biotechnol. 2008 Mar 20;134(1-2):171-80. CNTO 530: molecular pharmacology in human UT-7 EPO cells and pharmacokinetics and pharmacodynamics in mice. Bugelski PJ, Capocasale RJ, Makropoulos D, Marshall D, Fisher PW, Lu J, Achuthanandam R, Spinka-Doms T, Kwok D, Graden D, Volk A, Nesspor T, James IE, Huang C.
4. Cytometry A. 2008 Feb;73(2):148-59. Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice.  Capocasale RJ, Makropoulos DA, Achuthanandam R, Stowell N, Quinn J, Rafferty PA, O’Brien J, Emmell E, Bugelski PJ.
5. Pharm Res. 2008 Feb;25(2):369-78. Pharmacodynamics of recombinant human erythropoietin in murine bone marrow.  Bugelski PJ, Nesspor T, Volk A, O’Brien J, Makropoulos D, Shamberger K, Fisher PW, James I, Graden D, Capocasale RJ.
6. Int Immunopharmacol. 2007 Jun;7(6):761-72. Quantitative in vivo comparisons of the Fc gamma receptor-dependent agonist activities of different fucosylation variants of an immunoglobulin G antibody.  Scallon B, McCarthy S, Radewonuk J, Cai A, Naso M, Raju TS, Capocasale R.
7. Identification and Characterization of Bone Marrow Myeloid DEC205+Gr-1+CD11b+ Cell Subsets that Differentially Express Chemokine and Toll-like Receptors.  Roberta J. Lamb, Capocasale RJ, Duffy KE,  Sarisky RT, and Mbow ML. Journal of Immunology, 178 (12): 7833-9, 2007.
8. A Statistical Pattern Recognition Approach for Determining Cellular Viability and Lineage Phenotype in Cultured Cells and Murine Bone Marrow.  John Quinn+, P. W. Fisher‡, R. J. Capocasale, R.Achuthanandam‡, M. Kam♦, P. J. Bugelski, L.Hrebien.  Cytometry A. May 31, 2007.
9. Diminished expression of the type II receptor for TGFß in T cells from patients with Sezary Syndrome is not due to mutations in the receptor’s poly-A tract: limitations of RT-PCR in cDNA sequence analysis of homopolymeric base stretches.  Zhang, Q., Capocasale, R., Fox, F.E., Bedian, V., Vonderheid, E.C., Moore, J.S., Nowell, P.C., Haines, D.S. Wasik, M.A., Arch. Immunol.Ther. Exp, 50: 419- 427, 2002.
10. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice. Raymond S. Douglas, Edward Y. Woo, Renold J. Capocasale, Adam T. Tarshis, Peter C. Nowell, and Jonni S. Moore. Cell Immunol. Aug 1;179(2):126-37, 1997.
11. Chronic Lymphocytic Leukemia B Cells Are Resistant to the Apoptotic Effects of Transforming Growth Factor-β.  Raymond S. Douglas, Renold J. Capocasale, Roberta J. Lamb, Peter C. Nowell, and Jonni S. Moore.  Blood 89(3):941, 1997.
12. Reduced surface expression of transforming growth factor β receptor type II in mitogen-activated T cells from Sezary patients.  Renold J. Capocasale, Roberta J. Lamb, Eric C. Vonderheid, Floyd E. Fox, Alain H. Rook, Peter C. Nowell, and Jonni S. Moore.  Proc. Natl. Acad. Sci. USA 92:5501, 1995.
13. Richter’s Syndrome associated with loss of response to Transforming Growth Factor-Beta.  Peter C. Nowell, Jonni S. Moore, Floyd E. Fox, Renold J. Capocasale, Jeffery A. Kant, and Emmanuel C. Besa.  Leukemia Research 18(2):85, 1994.
14. Transforming growth factor-beta inhibits human T cell proliferation through multiple targets.  Fox FE, Capocasale RJ, Ford HC, Lamb RJ, Moore JS, Nowell PC.  Lymphokine and Cytokine Research 11(6):299, 1992.
15. Enhanced phosphorylation of a coated vesicle polypeptide in response to insulin stimulation of rat adipocytes.  Corvera S, Capocasale RJ.  J. Biol. Chem. 265:15963, 1990.
16. Increased Assembly of Clathrin Occurs in Response to Mitogenic Activation of Murine Lymphocytes.  Corvera S, Bartels J, Capocasale RJ, Cichowski K, Moore JS.  J. Biol. Chem. 264:12568, 1989.

 

PRESS RELEASES